258 related articles for article (PubMed ID: 32164378)
21. Noninvasive Prediction of High-Grade Prostate Cancer via Biparametric MRI Radiomics.
Gong L; Xu M; Fang M; Zou J; Yang S; Yu X; Xu D; Zhou L; Li H; He B; Wang Y; Fang X; Dong D; Tian J
J Magn Reson Imaging; 2020 Oct; 52(4):1102-1109. PubMed ID: 32212356
[TBL] [Abstract][Full Text] [Related]
22. What is the most effective tool for detecting prostate cancer using a standard MR scanner?
Osugi K; Tanimoto A; Nakashima J; Shinoda K; Hashiguchi A; Oya M; Jinzaki M; Kuribayashi S
Magn Reson Med Sci; 2013 Dec; 12(4):271-80. PubMed ID: 24172787
[TBL] [Abstract][Full Text] [Related]
23. Diffusion radiomics analysis of intratumoral heterogeneity in a murine prostate cancer model following radiotherapy: Pixelwise correlation with histology.
Lin YC; Lin G; Hong JH; Lin YP; Chen FH; Ng SH; Wang CC
J Magn Reson Imaging; 2017 Aug; 46(2):483-489. PubMed ID: 28176411
[TBL] [Abstract][Full Text] [Related]
24. Utility of computed diffusion-weighted MRI for predicting aggressiveness of prostate cancer.
Waseda Y; Yoshida S; Takahara T; Kwee TC; Matsuoka Y; Saito K; Kihara K; Fujii Y
J Magn Reson Imaging; 2017 Aug; 46(2):490-496. PubMed ID: 28152258
[TBL] [Abstract][Full Text] [Related]
25. Treatment effect prediction for sarcoma patients treated with preoperative radiotherapy using radiomics features from longitudinal diffusion-weighted MRIs.
Gao Y; Kalbasi A; Hsu W; Ruan D; Fu J; Shao J; Cao M; Wang C; Eilber FC; Bernthal N; Bukata S; Dry SM; Nelson SD; Kamrava M; Lewis J; Low DA; Steinberg M; Hu P; Yang Y
Phys Med Biol; 2020 Aug; 65(17):175006. PubMed ID: 32554891
[TBL] [Abstract][Full Text] [Related]
26. Characterization of prostate cancer with MR spectroscopic imaging and diffusion-weighted imaging at 3 Tesla.
Mazaheri Y; Shukla-Dave A; Goldman DA; Moskowitz CS; Takeda T; Reuter VE; Akin O; Hricak H
Magn Reson Imaging; 2019 Jan; 55():93-102. PubMed ID: 30176373
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of high b-value diffusion-weighted MRI for prostate cancer detection: a meta-analysis.
Godley KC; Syer TJ; Toms AP; Smith TO; Johnson G; Cameron D; Malcolm PN
Acta Radiol; 2018 Jan; 59(1):105-113. PubMed ID: 28376634
[TBL] [Abstract][Full Text] [Related]
28. Peritumoral Radiomics Strategy Based on Ensemble Learning for the Prediction of Gleason Grade Group of Prostate Cancer.
Qiu Y; Liu YF; Shu X; Qiao XF; Ai GY; He XJ
Acad Radiol; 2023 Sep; 30 Suppl 1():S1-S13. PubMed ID: 37393175
[TBL] [Abstract][Full Text] [Related]
29. High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis.
Wetter A; Nensa F; Lipponer C; Guberina N; Olbricht T; Schenck M; Schlosser TW; Gratz M; Lauenstein TC
Acta Radiol; 2015 Aug; 56(8):1009-15. PubMed ID: 25168023
[TBL] [Abstract][Full Text] [Related]
30. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
[TBL] [Abstract][Full Text] [Related]
31. The value of diffusion-weighted MRI for prostate cancer detection and localization.
Yağci AB; Ozari N; Aybek Z; Düzcan E
Diagn Interv Radiol; 2011 Jun; 17(2):130-4. PubMed ID: 20694948
[TBL] [Abstract][Full Text] [Related]
32. Development and validation of a logistic regression model to distinguish transition zone cancers from benign prostatic hyperplasia on multi-parametric prostate MRI.
Iyama Y; Nakaura T; Katahira K; Iyama A; Nagayama Y; Oda S; Utsunomiya D; Yamashita Y
Eur Radiol; 2017 Sep; 27(9):3600-3608. PubMed ID: 28289941
[TBL] [Abstract][Full Text] [Related]
33. Radiomics in diffusion data: a test-retest, inter- and intra-reader DWI phantom study.
Dreher C; Kuder TA; König F; Mlynarska-Bujny A; Tenconi C; Paech D; Schlemmer HP; Ladd ME; Bickelhaupt S
Clin Radiol; 2020 Oct; 75(10):798.e13-798.e22. PubMed ID: 32723501
[TBL] [Abstract][Full Text] [Related]
34. The Effect of Image Resampling on the Performance of Radiomics-Based Artificial Intelligence in Multicenter Prostate MRI.
Bleker J; Roest C; Yakar D; Huisman H; Kwee TC
J Magn Reson Imaging; 2024 May; 59(5):1800-1806. PubMed ID: 37572098
[TBL] [Abstract][Full Text] [Related]
35. Radiomics analysis of apparent diffusion coefficient in cervical cancer: A preliminary study on histological grade evaluation.
Liu Y; Zhang Y; Cheng R; Liu S; Qu F; Yin X; Wang Q; Xiao B; Ye Z
J Magn Reson Imaging; 2019 Jan; 49(1):280-290. PubMed ID: 29761595
[TBL] [Abstract][Full Text] [Related]
36. Characterisation of prostate cancer using texture analysis for diagnostic and prognostic monitoring.
Singh D; Kumar V; Das CJ; Singh A; Mehndiratta A
NMR Biomed; 2021 Jun; 34(6):e4495. PubMed ID: 33638244
[TBL] [Abstract][Full Text] [Related]
37. Semi-automatic classification of prostate cancer on multi-parametric MR imaging using a multi-channel 3D convolutional neural network.
Aldoj N; Lukas S; Dewey M; Penzkofer T
Eur Radiol; 2020 Feb; 30(2):1243-1253. PubMed ID: 31468158
[TBL] [Abstract][Full Text] [Related]
38. Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.
Yuan Q; Costa DN; Sénégas J; Xi Y; Wiethoff AJ; Rofsky NM; Roehrborn C; Lenkinski RE; Pedrosa I
J Magn Reson Imaging; 2017 Mar; 45(3):908-916. PubMed ID: 27442039
[TBL] [Abstract][Full Text] [Related]
39. Epithelial salivary gland tumors: Utility of radiomics analysis based on diffusion-weighted imaging for differentiation of benign from malignant tumors.
Shao S; Mao N; Liu W; Cui J; Xue X; Cheng J; Zheng N; Wang B
J Xray Sci Technol; 2020; 28(4):799-808. PubMed ID: 32538891
[TBL] [Abstract][Full Text] [Related]
40. MRI-based radiomics models to assess prostate cancer, extracapsular extension and positive surgical margins.
He D; Wang X; Fu C; Wei X; Bao J; Ji X; Bai H; Xia W; Gao X; Huang Y; Hou J
Cancer Imaging; 2021 Jul; 21(1):46. PubMed ID: 34225808
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
